I-Flow ON-Q Pump Recall Issued for Models With ONDEMAND Bolus Button

Several models of the I-Flow On-Q pain pump have been recalled, due to problems with the ONDEMAND bolus button featured on some devices, which may result in a risk of drug overdose. 

I-Flow Corporation sent a recall notice (PDF) in May 2012 to customers who purchased an On-Q pump with ONDEMAND bolus button. However, the FDA indicated last week that the action has been categorized as a class 1 medical device recall, suggesting that patients face a reasonably probability of serious adverse health consequences or death if the device is used.

The I-Flow On-Q pump recall affects devices manufactured from October 18, 2002 through April 30, 2012, with the ONDEMAND bolus button. The pumps are used for continuous and intermittent delivery of medications, such as local anesthetics or narcotics, to a surgical site before, during or after surgery for anesthetic or pain management.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

As a result of problems with some I-Flow On-Q pumps, the ONDEMAND bolus button may not lock down when depressed or may give a false reading on the refill indicator. This could lead to patients being injected with drugs faster than expected, potentially causing a drug overdose or other injuries, including a serious risk of death.

Lawsuits Over I-Flow On-Q Pumps

In recent years, I-Flow Corp. has faced a number of product liability lawsuits over their On-Q pump, involving cases where the device was used following arthroscopic shoulder surgery to deliver certain pain medication directly to the shoulder joint.

Studies have found that such intra-articular use of shoulder pain pumps can lead to the development of chondrolysis, a regenerative disease that causes loss of cartilage in the joint. Symptoms of the condition include a decreased range of motion, pain, as well as popping and grinding of the joint, which tend to develop during the months after use of the pain pump as use of the shoulder increases following the arthroscopic surgery.

Similar shoulder pain pump lawsuits have been filed in state and federal courts throughout the United States against manufacturers of other devices, including Stryker Corp., Breg, DePuy, Inc. and Smith & Nephew, Inc. All of the complaints involve similar allegations that the manufacturers ignored signs that the pain pumps may cause substantial damage to the shoulder joint, continuing to promote intra-articular, despite a failure to obtain FDA approval for such use.

1 Comments

  • LaurelOctober 4, 2016 at 12:04 pm

    Extensive foot surgery was performed on Oct 3rd, 2016. at Abbott Northwestern Hospital in Minneapolis, MN A catheter was installed on the side of my leg, and a pump was connected ...the On Q Pain Block pump. Not only did the lock break and the Bolus button fell off but during the night I woke up to the pump squirting me, the walls , and everywhere until it was completely deflated. What are my [Show More]Extensive foot surgery was performed on Oct 3rd, 2016. at Abbott Northwestern Hospital in Minneapolis, MN A catheter was installed on the side of my leg, and a pump was connected ...the On Q Pain Block pump. Not only did the lock break and the Bolus button fell off but during the night I woke up to the pump squirting me, the walls , and everywhere until it was completely deflated. What are my options??

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted yesterday)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.

AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California
AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California (Posted 2 days ago)

U.S. JPML has transferred all AngioDynamics port catheter lawsuits to the U.S. District Court for the Southern District of California, for coordinated discovery and pretrial proceedings as part of a federal MDL (multidistrict litigation).